中國宏光(08646.HK)升級現有玻璃生產設施 擴大及提升產品組合
中國宏光(08646.HK)公布,於今年6月18日,集團之附屬揭陽市宏光鍍膜玻璃與一家中國公司訂立設備購買協議,以升級集團現有生產設施,加強鍍膜玻璃之生產效能及讓公司具備量產雙銀Low-E玻璃的能力,因而擴大及提升產品組合。
升級程序完成後,預計集團鍍膜玻璃及雙銀Low-E玻璃的設計年產能將分別達到約280萬平方米及140萬平方米。公司將透過經營活動現金流以及動用由公司股份於香港聯交所GEM上市所得款項撥付是次升級程序。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.